Skip to main content
Erschienen in: Diabetologia 1/2005

01.01.2005 | Article

Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells

verfasst von: R. B. Ceddia, R. Somwar, A. Maida, X. Fang, G. Bikopoulos, G. Sweeney

Erschienen in: Diabetologia | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to determine whether adiponectin elicits glucose uptake via increased GLUT4 translocation and to investigate the metabolic fate of glucose in skeletal muscle cells treated with globular adiponectin.

Materials and methods

Basal and insulin-stimulated 2-deoxy-d-[3H]glucose uptake, cell surface myc-tagged GLUT4 content, production of 14CO2 by oxidation of d-[U-14C]glucose and [1-14C]oleate, and incorporation of d-[U-14C]glucose into glycogen and lactate were measured in the presence and absence of globular adiponectin.

Results

RT-PCR and Western blot analysis revealed that L6 cells and rat skeletal muscle cells express AdipoR1 mRNA and protein. Globular adiponectin increased both GLUT4 translocation and glucose uptake by increasing the transport V max of glucose without altering the K m. Interestingly, the incorporation of d-[U-14C]glucose into glycogen under basal and insulin-stimulated conditions was significantly decreased by globular adiponectin, whereas lactate production was increased. Furthermore, globular adiponectin did not affect glucose oxidation, but enhanced phosphorylation of AMP kinase and acetyl-CoA carboxylase, and fatty acid oxidation.

Conclusions/interpretation

The present study is the first to show that globular adiponectin increases glucose uptake in skeletal muscle cells via GLUT4 translocation and subsequently reduces the rate of glycogen synthesis and shifts glucose metabolism toward lactate production. These effects are consistent with the increased phosphorylation of AMP kinase and acetyl-CoA carboxylase and oxidation of fatty acids induced by globular adiponectin.
Literatur
1.
Zurück zum Zitat Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749CrossRefPubMed Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749CrossRefPubMed
2.
Zurück zum Zitat Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84–89CrossRefPubMed Berg AH, Combs TP, Scherer PE (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84–89CrossRefPubMed
3.
Zurück zum Zitat Pajvani UB, Scherer PE (2003) Adiponectin: systemic contributor to insulin sensitivity. Curr Diabetes Rep 3:207–213 Pajvani UB, Scherer PE (2003) Adiponectin: systemic contributor to insulin sensitivity. Curr Diabetes Rep 3:207–213
4.
Zurück zum Zitat Wolf G (2003) Adiponectin: a regulator of energy homeostasis. Nutr Rev 61:290–292PubMed Wolf G (2003) Adiponectin: a regulator of energy homeostasis. Nutr Rev 61:290–292PubMed
5.
Zurück zum Zitat Tsao TS, Lodish HF, Fruebis J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440:213–221 Tsao TS, Lodish HF, Fruebis J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol 440:213–221
6.
Zurück zum Zitat Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769CrossRefPubMed Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769CrossRefPubMed
7.
Zurück zum Zitat Yamauchi T, Kamon J, Waki H et al (2003) Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J Biol Chem 278:2461–2468PubMed Yamauchi T, Kamon J, Waki H et al (2003) Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J Biol Chem 278:2461–2468PubMed
8.
Zurück zum Zitat Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed
9.
Zurück zum Zitat Fruebis J, Tsao TS, Javorschi S et al (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98:2005–2010PubMed Fruebis J, Tsao TS, Javorschi S et al (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98:2005–2010PubMed
10.
Zurück zum Zitat Tomas E, Tsao TS, Saha AK et al (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99:16309–16313PubMed Tomas E, Tsao TS, Saha AK et al (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99:16309–16313PubMed
11.
Zurück zum Zitat Maeda N, Shimomura I, Kishida K et al (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–737CrossRefPubMed Maeda N, Shimomura I, Kishida K et al (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–737CrossRefPubMed
12.
Zurück zum Zitat Tremblay F, Dubois MJ, Marette A (2003) Regulation of GLUT4 traffic and function by insulin and contraction in skeletal muscle. Front Biosci 8:d1072–d1084 Tremblay F, Dubois MJ, Marette A (2003) Regulation of GLUT4 traffic and function by insulin and contraction in skeletal muscle. Front Biosci 8:d1072–d1084
13.
Zurück zum Zitat Somwar R, Niu W, Kim DY et al (2001) Differential effects of phosphatidylinositol 3-kinase inhibition on intracellular signals regulating GLUT4 translocation and glucose transport. J Biol Chem 276:46079–46087PubMed Somwar R, Niu W, Kim DY et al (2001) Differential effects of phosphatidylinositol 3-kinase inhibition on intracellular signals regulating GLUT4 translocation and glucose transport. J Biol Chem 276:46079–46087PubMed
14.
Zurück zum Zitat Sweeney G, Garg R, Ceddia R et al (2004) Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes translocation and incorporation of GLUT4 into the plasma membrane of muscle and fat cells without increasing transport. J Biol Chem 279:32233–32242CrossRefPubMed Sweeney G, Garg R, Ceddia R et al (2004) Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes translocation and incorporation of GLUT4 into the plasma membrane of muscle and fat cells without increasing transport. J Biol Chem 279:32233–32242CrossRefPubMed
15.
Zurück zum Zitat Hardie DG (2004) AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med Sci Sports Exerc 36:28–34PubMed Hardie DG (2004) AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med Sci Sports Exerc 36:28–34PubMed
16.
Zurück zum Zitat Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176PubMed Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171–176PubMed
17.
Zurück zum Zitat Tajmir P, Kwan JJ, Kessas M, Mozammel S, Sweeney G (2003) Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes. J Cell Physiol 197:122–130PubMed Tajmir P, Kwan JJ, Kessas M, Mozammel S, Sweeney G (2003) Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes. J Cell Physiol 197:122–130PubMed
18.
Zurück zum Zitat Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A (1999) An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274:10071–10078CrossRefPubMed Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A (1999) An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274:10071–10078CrossRefPubMed
19.
Zurück zum Zitat Sumitani S, Ramlal T, Liu Z, Klip A (1995) Expression of syntaxin 4 in rat skeletal muscle and rat skeletal muscle cells in culture. Biochem Biophys Res Commun 213:462–468 Sumitani S, Ramlal T, Liu Z, Klip A (1995) Expression of syntaxin 4 in rat skeletal muscle and rat skeletal muscle cells in culture. Biochem Biophys Res Commun 213:462–468
20.
Zurück zum Zitat Somwar R, Kim DY, Sweeney G et al (2001) GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochem J 359:639–649PubMed Somwar R, Kim DY, Sweeney G et al (2001) GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase. Biochem J 359:639–649PubMed
21.
Zurück zum Zitat Ceddia R, Sweeney G (2004) Creatine increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells. J Physiol 555:409–421PubMed Ceddia R, Sweeney G (2004) Creatine increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells. J Physiol 555:409–421PubMed
22.
Zurück zum Zitat Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558–565PubMed Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229:558–565PubMed
23.
Zurück zum Zitat Waki H, Yamauchi T, Kamon J et al (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363CrossRefPubMed Waki H, Yamauchi T, Kamon J et al (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363CrossRefPubMed
24.
Zurück zum Zitat Russell RR III, Bergeron R, Shulman GI, Young LH (1999) Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643–H649PubMed Russell RR III, Bergeron R, Shulman GI, Young LH (1999) Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643–H649PubMed
25.
Zurück zum Zitat Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667–1671PubMed Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW (1999) 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48:1667–1671PubMed
26.
Zurück zum Zitat Abbud W, Habinowski S, Zhang JZ et al (2000) Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 380:347–352PubMed Abbud W, Habinowski S, Zhang JZ et al (2000) Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 380:347–352PubMed
27.
Zurück zum Zitat Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ (2003) Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52:1355–1363PubMed Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ (2003) Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52:1355–1363PubMed
28.
Zurück zum Zitat Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683PubMed Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683PubMed
29.
Zurück zum Zitat Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMed Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMed
30.
Zurück zum Zitat Tsao TS, Tomas E, Murrey HE et al (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 278 50810–50817PubMed Tsao TS, Tomas E, Murrey HE et al (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 278 50810–50817PubMed
31.
Zurück zum Zitat Carling D, Hardie DG (1989) The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1012:81–86PubMed Carling D, Hardie DG (1989) The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1012:81–86PubMed
32.
Zurück zum Zitat Hudson ER, Pan DA, James J et al (2003) A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13:861–866 Hudson ER, Pan DA, James J et al (2003) A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13:861–866
33.
Zurück zum Zitat Polekhina G, Gupta A, Michell BJ et al (2003) AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 13:867–871 Polekhina G, Gupta A, Michell BJ et al (2003) AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 13:867–871
34.
Zurück zum Zitat Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA (2002) Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51:284–292PubMed Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA (2002) Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51:284–292PubMed
35.
Zurück zum Zitat Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178:373–383PubMed Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178:373–383PubMed
36.
Zurück zum Zitat Iglesias MA, Ye JM, Frangioudakis G et al (2002) AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51:2886–2894PubMed Iglesias MA, Ye JM, Frangioudakis G et al (2002) AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51:2886–2894PubMed
37.
Zurück zum Zitat Carling D, Fryer LG, Woods A, Daniel T, Jarvie SL, Whitrow H (2003) Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase. Biochem Soc Trans 31:1157–1160PubMed Carling D, Fryer LG, Woods A, Daniel T, Jarvie SL, Whitrow H (2003) Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase. Biochem Soc Trans 31:1157–1160PubMed
Metadaten
Titel
Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells
verfasst von
R. B. Ceddia
R. Somwar
A. Maida
X. Fang
G. Bikopoulos
G. Sweeney
Publikationsdatum
01.01.2005
Erschienen in
Diabetologia / Ausgabe 1/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1609-y

Weitere Artikel der Ausgabe 1/2005

Diabetologia 1/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.